Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

French health minister confirms vaccination could start by end of year

11/26/2020 | 06:12am EST

PARIS, Nov 26 (Reuters) - French Health Minister Oliver Veran confirmed on Thursday France could start rolling out COVID-19 vaccines by the end of the year, stressing the need for authorities to be transparent about the process given French citizens' high level of scepticism towards vaccinations.

During a news conference detailing how France's second national lockdown is about to be gradually unwound, Veran said the logistical aspects of the vaccination program will be detailed next week. (Reporting by Sudip Kar-Gupta and Benoit Van Overstraeten; Editing by Toby Chopra)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -2.18% 7779 Delayed Quote.8.57%
GLAXOSMITHKLINE PLC -0.64% 1400.8 Delayed Quote.5.05%
MODERNA, INC. 7.09% 162.4232 Delayed Quote.45.35%
SANOFI -2.47% 79.07 Real-time Quote.3.01%
All news about ASTRAZENECA PLC
05:54pOxford scientists expect some vaccine data on UK mutant virus by next week
RE
05:43pSHAREHOLDER ACTION ALERT : The Schall Law Firm Announces the Filing of a Class A..
BU
05:22pASTRAZENECA : EU to Push AstraZeneca on Vaccine Delivery Agreement -- Update
DJ
05:03pBritish shares drop as lockdowns strain mining stocks; AstraZeneca weighs
RE
04:52pASTRAZENECA : Oxford scientists expect some vaccine data on UK mutant virus by n..
RE
04:39pAZN EQUITY ALERT : Labaton Sucharow Announces Filing of Securities Class Action ..
BU
03:40pFrance's Sanofi to help rival Pfizer-BioNTech make vaccines
AQ
03:39pASTRAZENECA : Tensions rise as AstraZeneca, EU hold vaccine delivery talks
AQ
03:38pASTRAZENECA : uspicious package' evacuates COVID-19 vaccine plant in Wales
AQ
03:31pAZN EQUITY ALERT : Rosen Law Firm Announces Filing of Securities Class Action La..
BU
More news
Financials (USD)
Sales 2020 26 379 M - -
Net income 2020 2 956 M - -
Net Debt 2020 13 464 M - -
P/E ratio 2020 43,7x
Yield 2020 2,58%
Capitalization 143 B 143 B -
EV / Sales 2020 5,95x
EV / Sales 2021 5,10x
Nbr of Employees 70 600
Free-Float 95,7%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Average target price 127,03 $
Last Close Price 109,27 $
Spread / Highest target 43,8%
Spread / Average Target 16,3%
Spread / Lowest Target -17,4%
EPS Revisions
Managers and Directors
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Pam P. Cheng Executive VP-Operations & Information Technology
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC8.57%143 360
JOHNSON & JOHNSON8.32%448 796
ROCHE HOLDING AG4.51%312 213
NOVARTIS AG0.81%214 457
PFIZER INC.1.36%207 384
MERCK & CO., INC.-1.89%203 035